JNJ | Johnson & Johnson Stock Overview

(Stock Exchange: NYSE)

Day's Range	151.81 - 153.25
52 Week Range	143.13 - 168.85
Beta	0.50
Implied Volatility	18.26%
IV Rank	35.14%
Day's Volume	5,698,149
Average Volume	6,280,607
Shares Outstanding	2,407,620,000
Market Cap	368,630,698,200
Sector	Healthcare
Industry	Drug Manufacturers - General
IPO Date	1943-01-02

Valuation
Profitability
Growth
Health
P/E Ratio	25.35
Forward P/E Ratio	14.82
EPS	6.04
1YR Price Target	175.00
Dividend Yield	3.24%
Dividend Per Share	4.96
Dividend ExDate	2023-11-20
Dividend PayDate	2023-12-05
Employees	131,900
Country	USA
Website	JNJ

Johnson & Johnson, together with its subsidiaries, researches, develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment provides skin health/beauty products under the AVEENO, CLEAN & CLEAR, DR. CI:LABO, NEUTROGENA, and OGX brands; baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; TYLENOL acetaminophen products; SUDAFED cold, flu, and allergy products; BENADRYL and ZYRTEC allergy products; MOTRIN IB ibuprofen products; NICORETTE smoking cessation products; and PEPCID acid reflux products. This segment also offers STAYFREE and CAREFREE sanitary pads; o.b. tampons; adhesive bandages under the BAND-AID brand; and first aid products under the NEOSPORIN brand. It serves general public, retail outlets, and distributors.

JNJ's peers: ABBV, ABT, AMGN, AMRN, AZN, BIIB, BMY, GILD, GSK, MRK, PFE, LLY, NVS, OGN, SNY

*Chart delayed

Analyzing fundamentals for JNJ we got that it has weak fundamentals where Valuation is considered to be fairly valued, Profitability is moderate, Growth is very bad and Health is very weak. For more detailed analysis please see JNJ Fundamentals page.

Watching at JNJ technicals we can see that long-term trend is bearish, the same as bearish middle-term trend, as well as bearish short-term trend. More technicals details can be found on JNJ Technicals page.